Clinical Trial Update: External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease [NA]

View source ↗

Summary

This completed clinical trial evaluated External Counterpulsation (ECP) as a method to promote collateral growth in patients with Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Coronary Artery Disease | NA | Status: COMPLETED